Biotech

Latest Articles

Cassava pays $40M over apparently deceiving Alzheimer's update

.Cassava Sciences has agreed to pay $40 million to deal with an investigation in to claims it made m...

Merck bags choices on Evaxion's AI-designed vaccine candidates

.Merck &amp Co. has actually gotten possibilities on two Evaxion Biotech vaccination candidates, spe...

Enanta's RSV antiviral crushes popular lots in problem study

.Enanta Pharmaceuticals has actually connected its own respiratory syncytial infection (RSV) antivir...

Biogen containers SAGE-324 collaboration after vital agitation fall short

.Biogen has actually conducted the last rites to its own cooperation with Sage Therapeutics on SAGE-...

AbbVie Parkinson's drug from $8.7 B Cerevel purchase scores

.On the very same day that some Parkinson's condition drugs are being actually questioned, AbbVie ha...

Arch shuts $3B-plus fund to foster biopharma startups

.On the heels of a $3 billion fund coming from Bain Funding Lifestyle Sciences, Arch Project Allies ...

Orion to make use of Aitia's 'digital doubles' to discover brand-new cancer drugs

.Finnish biotech Orion has spied potential in Aitia's "digital twin" technology to develop brand new...

Windtree's surprise med brings up blood pressure in most recent stage 2 win

.While Windtree Therapeutics has actually battled to increase the economic origins needed to have to...

2 cancer biotechs merge, developing global footprint

.OncoC4 is taking AcroImmune-- and its internal medical manufacturing capabilities-- under its wing ...

Amgen documents first period 3 win for $400M eczema medicine

.Amgen has actually discussed (PDF) the initial stage 3 data on its own $400 thousand eczema medicin...

Biogen, UCB record phase 3 lupus succeed after falling short earlier test

.Biogen as well as UCB's bet one's bottom dollar developing right into stage 3 on the back of a fail...

Aptadir wishes brand new RNA preventions can easily reverse difficult cancers

.Italian biotech Aptadir Therapies has released with the assurance that its own pipeline of preclini...

Wave surfs DMD excellence to regulatory authorities' doors, sending stockpile

.Wave Lifestyle Sciences has actually satisfied its own target in a Duchenne muscular dystrophy (DMD...

Sanofi picks brand-new CSO from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, using up the ...

Achilles splashes cell treatment program, braces for discharges after overlooking 'industrial viability' objectives

.Achilles Rehabs has shreded its technique. The British biotech is actually stopping work on its own...

Aligos proclaims period 2 MASH gain, reducing liver body fat as much as 46%

.Aligos Rehabs is actually declaring a midstage gain in metabolic-dysfunction affiliated steatohepat...

Basilea scores $268M BARDA funding for antifungals, prescription antibiotics

.Basilea Pharmaceutica's work creating brand-new antifungals has actually gotten a substantial impro...

Capricor markets Europe liberties to late-stage DMD treatment for $35M

.Possessing actually scooped up the U.S. legal rights to Capricor Therapies' late-stage Duchenne mus...

FDA scraps adcomm for Applied's rare illness medicine

.After pushing back the selection date for Applied Therapies' metabolic disorder medication govorest...

Novo inks $600M NanoVation deal to analyze hereditary medications ex-liver

.Novo Nordisk is actually proceeding its press right into genetic medicines, accepting to compensate...